Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Villaplana MCP"'
Autor:
Pérez-Pérez J; Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain.; Centro Investigación Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., García-López S; Medical Department, Roche Pharma, Madrid, Spain., Valle TF; Department of Neurology, University Hospital Cruces, Neurodegenerative Disease Group Health Research Institute of Bizkaia (BioBizkaia), Neuroscience Department University of the Basque Country, Leioa, Spain., Painous C; Parkinson and Movement Disorders Unit, Neurology Service, Hospital Clínic Universitari, Barcelona, Spain., Querol-Pascual MR; Department of Neurology, Hospital de Badajoz, Badajoz, Spain., Ruiz PJG; Movement Disorders Unit, Department of Neurology, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain., Diago EB; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Saragossa, Spain.; Research Group of Movement Disorders and Headache (GIIS070), Instituto de Investigación Sanitaria de Aragón (IIS-Aragón), Zaragozaa, Spain., Cubo Delgado E; Hospital Universitario de Burgos, University of Burgos, Burgos, Spain., Pastor BV; Servicio Neurología, Hospital Universitari Son Espases, Palma, Spain., Villaplana MCP; Hospital Universitario La Fe de Valencia, Valencia, Spain., Santana IM; Unidad de Trastornos del Movimiento, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Blázquez Estrada M; Hospital Universitario Central de Asturias, Asturias, Spain., Garride MC; Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain., Álvarez C; Medical Department, Roche Pharma, Madrid, Spain., Maurino J; Medical Department, Roche Pharma, Madrid, Spain., de Prado A; Real World Evidence, IQVIA Information S.A, Madrid, Spain., López-Sendón JL; Department of Neurology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain. jlsendonmoreno@salud.madrid.org.
Publikováno v:
Neurology and therapy [Neurol Ther] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.
Autor:
Pérez-Pérez J; Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain.; Centro Investigación Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., García-López S; Medical Department, Roche Pharma, Madrid, Spain., Valle TF; Department of Neurology, University Hospital Cruces, Neurodegenerative Disease Group Health Research Institute of Bizkaia (BioBizkaia), Neuroscience Department University of the Basque Country, Leioa, Spain., Painous C; Parkinson and Movement Disorders Unit, Neurology Service, Hospital Clínic Universitari, Barcelona, Spain., Querol-Pascual MR; Department of Neurology, Hospital de Badajoz, Badajoz, Spain., Ruiz PJG; Movement Disorders Unit, Department of Neurology, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain., Diago EB; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Saragossa, Spain.; Research Group of Movement Disorders and Headache (GIIS070), Instituto de Investigación Sanitaria de Aragón (IIS-Aragón), Zaragozaa, Spain., Cubo Delgado E; Hospital Universitario de Burgos, University of Burgos, Burgos, Spain., Pastor BV; Servicio Neurología, Hospital Universitari Son Espases, Palma, Spain., Villaplana MCP; Hospital Universitario La Fe de Valencia, Valencia, Spain., Santana IM; Unidad de Trastornos del Movimiento, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Blázquez Estrada M; Hospital Universitario Central de Asturias, Asturias, Spain., Garride MC; Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain., Álvarez C; Medical Department, Roche Pharma, Madrid, Spain., Maurino J; Medical Department, Roche Pharma, Madrid, Spain., de Prado A; Real World Evidence, IQVIA Information S.A, Madrid, Spain., López-Sendón JL; Department of Neurology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain. jlsendonmoreno@salud.madrid.org.
Publikováno v:
Neurology and therapy [Neurol Ther] 2024 Oct 07. Date of Electronic Publication: 2024 Oct 07.